Institutional investors control 47.95% of the outstanding shares in GERN. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended September 2014, these large investors purchased a net $3.6 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CANDRIAM BELGIUM SA Bought 450.0 Thousand shares of Geron Corp